Baclofen in the treatment of spasticity
P Hudgson, D Weightman, P Hudgson, D Weightman
Abstract
Baclofendagger (Lioresal), a derivative of gamma-aminobutyric acid, was introduced in 1966 as a possible treatment for spasticity due to corticospinal tract lesions. Preliminary studies suggested that it may be more effective than other spasmolytic agents currently available, and a double-blind controlled trial in a group of 23 patients against placebo has shown it to be significantly more effective.
References
- Pharmacol Rev. 1965 Dec;17(4):347-91
- J Neurol Sci. 1967 Jul-Aug;5(1):33-7
- J Neurol Neurosurg Psychiatry. 1970 Aug;33(4):464-8
- Acta Neurol Scand. 1970;46(3):257-66
- Lancet. 1959 Dec 19;2(7112):1099-102
Source: PubMed